Thrombolysis with alteplase 3–4.5 hours after acute ischaemic stroke: the first multicentre, phase III trial in China

BACKGROUND AND PURPOSE: Data on the efficacy and safety of alteplase for acute ischaemic stroke (AIS) administered 3–4.5 hours after the onset of stroke symptoms in Chinese patients is limited. We sought to determine whether AIS patients would benefit from thrombolysis with alteplase between 3 and 4...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Stroke Vasc Neurol
Egile Nagusiak: Zheng, Huaguang, Yang, Yi, Chen, Huisheng, Li, Chuanling, Chen, Yangkun, Shi, Fu-Dong, Yang, Li, Cui, Xiaoping, Lu, Zuneng, Liang, Yanling, Cui, Songbiao, Xu, Anding, Wu, Yiqing, Sun, Yaqing, Wang, Yongjun
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMJ Publishing Group 2020
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7548519/
https://ncbi.nlm.nih.gov/pubmed/32467323
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/svn-2020-000337
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak